Pacritinib and Digoxin: Interaction Details
- Digoxin
- CardoxinDigitekLanoxicaps +2 more
- Pacritinib
- Vonjo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Pacritinib and Digoxin interaction:
Digoxin
- Cardoxin
- Digitek
- Lanoxicaps
- Lanoxin
- Digox
What Happens When You Take Pacritinib With Digoxin
What can happen when they are taken together (rated Major)
Increased digoxin exposure and an increased risk of digoxin-related adverse reactions
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Pacritinib inhibits , and digoxin is a P-gp with a (NTI), so using them together may raise digoxin exposure and, with it, the risk of digoxin-related adverse reactions. When the two drugs are given together, digoxin-related adverse reactions should be monitored for more often.
Serum digoxin concentrations should be measured before with pacritinib begins and should continue to be monitored afterward. A drug interaction study found that giving pacritinib 200 mg twice daily with a 0.25 mg dose of digoxin (a P-gp substrate) raised digoxin by 1.29-fold and by 1.15-fold.1
The Pacritinib and Digoxin Interaction, Explained
Pacritinib can raise the amount of digoxin in your body. Pacritinib slows a pump () that helps clear digoxin, so a bit more digoxin stays in your blood. In a study the increase was modest (about 15% more overall exposure, and about 29% higher peak level). Digoxin is a drug where small changes matter, so higher levels could cause nausea, vomiting, vision changes (like blurred or yellow-tinged vision), a very slow or irregular heartbeat, or dizziness.
This is manageable. Keep taking both as prescribed, and ask your pharmacist or doctor about blood tests to check your digoxin level. Let them know right away if you notice any of these symptoms.
Mechanism: Pacritinib inhibits -mediated efflux of digoxin (P-gp , ), increasing digoxin exposure. Neither drug's effect depends on activation.
- Magnitude: In an interaction study, pacritinib 200 mg BID with digoxin 0.25 mg increased digoxin 1.29-fold and 1.15-fold.
- Risk: Increased digoxin toxicity ( effects, visual disturbance, bradyarrhythmias, AV block, ventricular ). Small rises matter given the NTI.
- Onset/evidence: Onset unspecified; evidence rated probable; severity major.
- Management: Measure serum digoxin before starting pacritinib, continue monitoring concentrations, and monitor more frequently for digoxin adverse reactions. Dose individualization may be needed.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Pacritinib and Digoxin Interact
The likely mechanism
of -mediated efflux transport of digoxin
How to Manage the Pacritinib and Digoxin Interaction
Your care team can manage this combination with extra monitoring and, if needed, a tailored digoxin dose.
- Your team will likely check a digoxin blood level before you start pacritinib and keep checking it afterward.
- They may watch you more closely for signs of too much digoxin.
- Your digoxin dose may need to be adjusted and individualized by your care team.
What you can do: keep taking both medicines as prescribed, and do not change doses on your own. Contact your pharmacist or prescriber promptly if you have nausea, vomiting, vision changes, a slow or uneven heartbeat, or unusual dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Pacritinib or Digoxin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: VONJO oral capsules, pacritinib oral capsules
A drug interaction study found that giving pacritinib 200 mg twice daily together with digoxin (a ) 0.25 mg raised digoxin by 1.29-fold and by 1.15-fold.1
Pacritinib and Digoxin: Common Questions
How serious is the Pacritinib and Digoxin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Pacritinib and Digoxin interaction managed?
Your care team can manage this combination with extra monitoring and, if needed, a tailored digoxin dose. Your team will likely check a digoxin blood level before you start pacritinib and keep checking it afterward. They may watch you more closely for signs of too much digoxin. Your digoxin dose may need to be adjusted and individualized by your care team. What you can do: keep taking both medicin… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Pacritinib and Digoxin Interaction
Ask in your own words about taking Pacritinib and Digoxin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Other Serious Interactions of Pacritinib and Digoxin
Also serious with Digoxin
Also serious with Pacritinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Digoxin
- AloeMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Blue FlagMajor
- DanshenMajor
- European BuckthornMajor
- FoxgloveMajor
- Indian SnakerootMajor
- + 106 more
With Pacritinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 155 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.